Signals mentioning Honasa Consumer
- Honasa buys 58% of Fluence Pharma at ₹135 cr, pushes Mamaearth parent into nutraceuticals
- Honasa buys 58% of Fluence Pharma, opens nutraceuticals front beyond Mamaearth
- Honasa buys 58% of Fluence Pharma for Rs 135 cr, launches Honasa Health for nutraceuticals
- Honasa Consumer Acquires 58% Stake in Fluence Pharma, Enters Nutraceuticals
- Honasa Consumer, Rashi Peripherals in focus as Nifty tumbles 1.16% tracking KOSPI rout
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000-cr nutraceuticals via Honasa Health
- Honasa Buys 58% of Fluence Pharma for Rs 135 Cr, Launches Honasa Health for Nutraceuticals
- Honasa Consumer acquires 58% of Fluence Pharma at Rs 135 cr EV, launches Honasa Health subsidiary
- Honasa Buys 58% Of Fluence Pharma, Pushes Mamaearth Into Beauty-From-Within
- Honasa buys 58% of Fluence Pharma for ₹135 Cr, enters nutraceuticals via Honasa Health
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000 cr nutraceuticals market
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000-cr nutraceuticals category
- Honasa Consumer to acquire 58% of Fluence Pharma at Rs 135 cr EV, enters Rs 16,000 cr supplements market
- Honasa buys 58% of Fluence Pharma for Rs 135 Cr, launches Honasa Health for nutraceuticals push
- Honasa buys 58% of Fluence Pharma for Rs 135 Cr, launches Honasa Health for D2C wellness play
- Honasa Buys 58% of Fluence Pharma for ₹135 Cr, Launches Honasa Health for Nutraceuticals
- FMCG distribution moat erodes as ONDC, quick commerce flatten route-to-market
- L'Oréal takes majority stake in Innovist, valuing Bare Anatomy parent at up to $450M
- Honasa hires Richa Gupta as SVP to run ecommerce across marketplaces and quick commerce
- Lenskart slips 2.4% on ADIA ₹1,960 Cr exit; Honasa hits 52-week high on FY31 ₹5,500 Cr plan